Discover how automation is revolutionizing laboratory processes, changes in the regulatory landscape, and how labs can stay ...

insights from industryBernd GleixnerDivision President AutomationBruker Biopsin News Medical speaks to Bernd Gleixner, Division President Automation at Bruker Biospin, about the future of lab ...

The AI in lab automation market is driven by growing demand for enhanced data analysis, drug discovery acceleration, cloud-based solutions, intelligent robotics, and many more. The AI in lab ...

Telos Scientific Suggests Putting the Integration of Laboratory Automation on AutoPilot Telos Scientific is the developer of AutoPilot, a technology that can allow scientists who lack programming ...

In this interview, we speak to Mostafa ElSayed, CEO of Automata, about their new, open, integrated lab automation platform Automata LINQ and how it unlocks labs' people, space and potential. Please ...

Welcome to the 6th Annual Event in the Laboratory Automation Virtual Event Series! This free virtual conference is tailored for industry professionals interested in the most recent technological ...

Employee burnout rates in the healthcare sector were exceptionally high even before COVID-19. Burnout has a significant adverse influence on clinicians’ overall well-being, as well as their sense of ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The lab automation market is expected to surpass $8.36 billion globally in 2025 and reach ...

Rising companion animal ownership, increasing demand for rapid and accurate diagnostics, and expanding veterinary healthcare infrastructure are driving the growth of the veterinary lab automation ...

Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. No topic has been discussed more than Covid-19 in the past two ...